Army

Method of diagnosing stage or aggressiveness of breast and prostate cancer based on levels of fatty acid binding proteins

  • US Patent No. 7175981
  • Issued: February 13, 2007
  • Status: Expired
Medical & Biotechnology

A method of diagnosing the stage or aggressiveness of cancer and particularly breast and prostate cancer by measuring the deviation of levels of fatty acid binding proteins in mammalian tissue or body fluids from normal levels of fatty acid binding proteins. The invention relates to a family of key proteins called fatty acid binding proteins which are involved in metabolism of AA and other lipids and how they affect the proliferation of cancer cells.

Do you have questions or need more information on a specific technology? Let's talk.

Contact Us